-
Je něco špatně v tomto záznamu ?
Chronic venous disease and diabetic microangiopathy: pathophysiology and commonalities
G. Gastaldi, F. Pannier, K. Roztočil, M. Lugli, A. Mansilha, H. Haller, E. Rabe, MJ. VAN Rijn
Jazyk angličtina Země Itálie
Typ dokumentu časopisecké články
- MeSH
- chronická nemoc MeSH
- diabetes mellitus * MeSH
- diabetické angiopatie * diagnóza epidemiologie etiologie MeSH
- hypertenze * MeSH
- lidé MeSH
- vény MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Chronic venous disease and diabetes mellitus are highly prevalent and debilitating conditions affecting millions of individuals globally. Although these conditions are typically considered as separate entities, they often co-exist which may be important in both understanding their pathophysiology and determining the best treatment strategy. Diabetes mellitus is twice as common in patients with chronic venous disease compared with the general population. Notably, a large proportion of patients with diabetes mellitus present with venous disorders, although this is often overlooked. The etiology of chronic venous disease is multifactorial, involving hemodynamic, genetic, and environmental factors which result in changes to the venous endothelium and structural wall as well as inflammation. Inflammation, endothelial dysfunction and hyperfiltration or leakage, are commonly observed in diabetes mellitus and cause various diabetic microvascular complications. Both diseases are also influenced by the increased expression of adhesion molecules, chemokines, and cytokines, and are characterized by the presence of vessel hypertension. Consequently, despite differences in etiology, the pathophysiology of both chronic venous disease and diabetic microangiopathy appears to be driven by endothelial dysfunction and inflammation. Treatment strategies should take the co-existence of chronic venous disease and diabetic microangiopathy into account. Compression therapy is recommended in inflammatory conditions that have an edema component as seen in both chronic venous disease and diabetes mellitus. Lifestyle changes like weight loss and exercise, will improve metabolic state and lower inflammation and should be promoted in these patients. Additionally, both patient populations may benefit from venoactive drugs.
Department of Angiology and Vascular Surgery Hospital de S João Porto Portugal
Department of Dermatology University of Bonn Bonn Germany
Department of Dermatology University of Cologne Cologne Germany
Department of Vascular Surgery Erasmus Medical Center Rotterdam the Netherlands
Faculty of Medicine University of Porto Porto Portugal
Hannover Medical School Department of Nephrology and Hypertension Hannover Germany
Private Clinic Phlebology and Dermatology Bonn Germany
Unit of Vascular Surgery Cardiovascular Department Hesperia Hospital Modena Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003102
- 003
- CZ-PrNML
- 005
- 20220127150654.0
- 007
- ta
- 008
- 220113s2021 it f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.23736/S0392-9590.21.04664-2 $2 doi
- 035 __
- $a (PubMed)34547884
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Gastaldi, Giacomo $u Division of Endocrinology Diabetology Nutrition and Patient Education, Geneva University Hospitals, Geneva, Switzerland
- 245 10
- $a Chronic venous disease and diabetic microangiopathy: pathophysiology and commonalities / $c G. Gastaldi, F. Pannier, K. Roztočil, M. Lugli, A. Mansilha, H. Haller, E. Rabe, MJ. VAN Rijn
- 520 9_
- $a Chronic venous disease and diabetes mellitus are highly prevalent and debilitating conditions affecting millions of individuals globally. Although these conditions are typically considered as separate entities, they often co-exist which may be important in both understanding their pathophysiology and determining the best treatment strategy. Diabetes mellitus is twice as common in patients with chronic venous disease compared with the general population. Notably, a large proportion of patients with diabetes mellitus present with venous disorders, although this is often overlooked. The etiology of chronic venous disease is multifactorial, involving hemodynamic, genetic, and environmental factors which result in changes to the venous endothelium and structural wall as well as inflammation. Inflammation, endothelial dysfunction and hyperfiltration or leakage, are commonly observed in diabetes mellitus and cause various diabetic microvascular complications. Both diseases are also influenced by the increased expression of adhesion molecules, chemokines, and cytokines, and are characterized by the presence of vessel hypertension. Consequently, despite differences in etiology, the pathophysiology of both chronic venous disease and diabetic microangiopathy appears to be driven by endothelial dysfunction and inflammation. Treatment strategies should take the co-existence of chronic venous disease and diabetic microangiopathy into account. Compression therapy is recommended in inflammatory conditions that have an edema component as seen in both chronic venous disease and diabetes mellitus. Lifestyle changes like weight loss and exercise, will improve metabolic state and lower inflammation and should be promoted in these patients. Additionally, both patient populations may benefit from venoactive drugs.
- 650 _2
- $a chronická nemoc $7 D002908
- 650 12
- $a diabetes mellitus $7 D003920
- 650 12
- $a diabetické angiopatie $x diagnóza $x epidemiologie $x etiologie $7 D003925
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a hypertenze $7 D006973
- 650 _2
- $a vény $7 D014680
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pannier, Felizitas $u Private Clinic Phlebology and Dermatology, Bonn, Germany $u Department of Dermatology, University of Cologne, Cologne, Germany
- 700 1_
- $a Roztočil, Karel $u Department of Transplantational and Vascular Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Lugli, Marzia $u Unit of Vascular Surgery, Cardiovascular Department, Hesperia Hospital, Modena, Italy
- 700 1_
- $a Mansilha, Armando $u Faculty of Medicine, University of Porto, Porto, Portugal $u Department of Angiology and Vascular Surgery, Hospital de S. João, Porto, Portugal
- 700 1_
- $a Haller, Hermann $u Hannover Medical School, Department of Nephrology and Hypertension, Hannover, Germany
- 700 1_
- $a Rabe, Eberhard $u Department of Dermatology (Emeritus), University of Bonn, Bonn, Germany
- 700 1_
- $a VAN Rijn, Marie Josee $u Department of Vascular Surgery, Erasmus Medical Center, Rotterdam, the Netherlands - m.vanrijn@erasmusmc.nl
- 773 0_
- $w MED00002267 $t International angiology : a journal of the International Union of Angiology $x 1827-1839 $g Roč. 40, č. 6 (2021), s. 457-469
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34547884 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127150650 $b ABA008
- 999 __
- $a ok $b bmc $g 1750768 $s 1154251
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 40 $c 6 $d 457-469 $e 20210922 $i 1827-1839 $m International angiology $n Int Angiol $x MED00002267
- LZP __
- $a Pubmed-20220113